Observational study on factors affecting chronic heart failure prognosis
Official title: Cohort Study of Chronic Heart Failure
Run by Jiangsu Taizhou People's Hospital · NCT05960890 · Data updated 2026-11-12
This study looks at how different factors, like genetics and lifestyle, affect the health and future of people with chronic heart failure to help improve their care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Jiangsu Taizhou People's Hospital Academic / other |
| Locations | 1 site (Taizhou, Jiangsu) |
| Status | Recruiting |
| Started | June 8, 2023 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | May 20, 2026 |
| Trial ID | NCT05960890 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with specific types of cardiomyopathy and heart failure symptoms.
✕Probably not a fit
Patients with severe renal insufficiency, life expectancy less than 3 months, or cardiac insufficiency from correctable causes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify the factors influencing the prognosis of chronic heart failure in patients. It will collect various omics data, including phenotype, environmental exposure, intestinal microbiome, genome, metabolome, and noninvasive biomarkers, to understand their impact on clinical outcomes. The study focuses on patients with specific types of cardiomyopathy and heart failure symptoms. By analyzing this data, researchers hope to gain insights into improving patient management and outcomes.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management of chronic heart failure, ultimately improving patient outcomes.
How similar studies have gone: Other studies have explored similar factors in heart failure, but this specific approach to integrating multiple omics data is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years; 2. Fulfill at least one of the following criteria:①History of chronic heart failure;②New-onset heart failure with LVEF \<50%;③New-onset heart failure with LVEF≧50%,E/e'≧15 and BNP\>400 pg/mL/NT-proBNP(\<50 years, \>450 pg/mL; 50\~75 years, \>900 pg/mL; \>75 years, \>1800 pg/mL) 3. Etiology: dilated cardiomyopathy, hypertensive heart disease, ischaemic cardiomyopathy, Non-severe valvular heart disease; 4. Primary post-discharge therapy: oral medication; 5. Sign the informed consent form. Exclusion Criteria: 1. Patients with renal failure (Ccr\<30ml/min) or patients on dialysis therapy; 2. Various correctable secondary causes of cardiac insufficiency including hyperthyroid heart disease, anaemic heart disease, uncorrected congenital heart disease; severe valvular heart disease (including severe stenosis or closure of organic aortic and mitral valves); 3. Patients with indications for pacemaker implantation but have not received a pacemaker implant; 4. Patients with chronic obstructive pulmonary disease accompanied by type II respiratory failure. 5. Patients who cannot understand and sign an informed consent form. 6. Patients with mental illness, pregnant women, and other special populations.
Where it's running
-
Taizhou People's Hospital affiliated to Nanjing Medical University
Taizhou, Jiangsu, China Recruiting
Study contacts
- Principal investigator: Ming Chu, Doctor — Jiangsu Taizhou People's Hospital
- Study coordinator: Yucheng Wu, Doctor
- Email: 2567181759@qq.com
- Phone: +8618360010750
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.